『Why Ozempic Doesn't Work for Everyone』のカバーアート

Why Ozempic Doesn't Work for Everyone

Why Ozempic Doesn't Work for Everyone

著者： Inception Point Ai
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 Dr. Ben Synth cuts through the Ozempic hype to reveal why this weight-loss wonder drug fails nearly one in three users. Exploring genetics, gut bacteria, and dosing realities, this series delivers data-driven answers about who responds to GLP-1 medications and why your body might be wired differently.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai
エピソード
  • Why Ozempic Doesn't Work for Everyone - Unpack the science behind the hype with Dr. Ben Synth

    Why Ozempic Doesn't Work for Everyone - Unpack the science behind the hype with Dr. Ben Synth
    2026/04/07
    Join Dr. Ben Synth as he uncovers the surprising science behind why Ozempic works miracles for some but fails for others. Explore the genetics, gut bacteria, and biological factors determining whether your body responds to semaglutide—or shrugs it off. An honest, evidence-based investigation into why these drugs don't work for everyone.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    1 分
  • Why Ozempic Doesn't Work for Everyone - The Dose You're On Probably Isn't Enough

    Why Ozempic Doesn't Work for Everyone - The Dose You're On Probably Isn't Enough
    2026/04/07
    Ben Synth examines why most Ozempic users quit within a year, uncovering the gap between clinical trial doses and real-world prescriptions. He explores cost barriers, dosing problems, side effects, and supply shortages that create apparent non-responders who were actually under-treated—revealing how healthcare system failures, not just biology, drive disappointment with GLP-1 medications.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    26 分
  • Why Ozempic Doesn't Work for Everyone - Your Gut Bacteria Are Running the Show

    Why Ozempic Doesn't Work for Everyone - Your Gut Bacteria Are Running the Show
    2026/04/07
    Ben Synth explores why 10-18% of patients don't respond to GLP-1 drugs like Ozempic. New research reveals gut bacteria may be the missing link—they produce the same metabolic compounds these medications mimic. Your microbiome's health could determine whether semaglutide works or fails completely.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    24 分
まだレビューはありません